In a Grand Rounds presentation at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, Timothy Pawlik, MD, PhD, MPH, MTS, discusses the epidemiology and risk factors of intrahepatic cholangiocarcinoma. He further outlines the molecular pathogenesis, clinical diagnosis, surgical resection, staging systems, non-surgical therapy and future trials for this rare tumor.
Related Presenters
Timothy Pawlik, MD, PhD, MPH, MTS
Professor and Chair, Department of Surgery
The Urban Meyer II and Shelley Meyer Chair in Cancer Research
Surgeon-in-Chief, The Ohio State University Wexner Medical Center
Related Videos
